We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£120.99
Springer Malignant Lymphomas and Hodgkin's Disease Volume 66
Price data last checked 27 day(s) ago - will refresh soon
We'll watch every seller, every day. One email when your price arrives.
This is the most expensive it has ever been. Walk away.
£121 today · previous high £121 · all-time low £121
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 64 days • 64 data points (No recent data available)
Price Distribution
Price distribution over 64 days • 1 price levels
Price Analysis
Most common price: £121 (64 days, 100.0%)
Price range: £121 - £121
Price levels: 1 different prices over 64 days
Description
Key Features
Comprehensive reviews on malignant lymphomas and Hodgkin's disease to assist in clinical understanding.
Updates on the rapid growth of insight regarding the basic mechanisms of lymphomagenesis.
Detailed information on new therapeutic agents, including both cytotoxic and biologic options.
Coverage of emerging drug delivery strategies to assist in modern treatment planning.
Focus on the need for precise morphologic classification in diagnosing these diseases.
Expert analysis of how new developments are changing traditional standard approaches.
Product Specifications
- Brand
- Springer
- Format
- hardcover
- ASIN
- 0792321715
- Domain
- Amazon UK
- Release Date
- 31 July 1993
- Listed Since
- 09 December 2006
Barcode
No barcode data available
Similar Products You Might Like
Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems: 66 (Cancer Treatment and Research)
Springer
Aggressive Lymphomas (Hematologic Malignancies)
Springer
Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)
Springer
Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)
Springer
Springer Hodgkin's and Non-Hodgkin's Lymphoma - Research Book
Springer
Lymphoma: Diagnosis and Treatment: 43 (Current Clinical Oncology, 43)
Humana
Advances in Lymphoma Research: 85 (Cancer Treatment and Research, 85)
Springer
Rare Lymphomas (Hematologic Malignancies)
Springer
Skin Lymphoma: The Illustrated Guide
Wiley-Blackwell
Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)
Springer
Saunders Extranodal Lymphomas: Expert Consult - Online and Print
Saunders
Blut und Blutkrankheiten: Fünfte Völlig Neu Bearbeitete und Erweiterte Auflage: 2 / 7 (Handbuch der inneren Medizin, 2 / 7)
Springer
Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)
Springer
Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy: 165 (Cancer Treatment and Research, 165)
Springer
Histopathology of Non-Hodgkin’s Lymphomas: (Based on the Updated Kiel Classification)
Springer
Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)
Springer
Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)
Humana
Diagnosis and Therapy of Malignant Lymphoma: 46 (Recent Results in Cancer Research, 46)
Springer
Lymphoma: Methods and Protocols: 2865 (Methods in Molecular Biology, 2865)
Humana
Humana Lymphoma: Methods and Protocols - Methods in Molecular Biology
Humana
Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)
Springer
Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)
Springer
T-Cell and NK-Cell Lymphomas: From Biology to Novel Therapies: 176 (Cancer Treatment and Research, 176)
Springer
Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)
Springer